About Neu-Laxova syndrome due to 3-phosphoglycerate dehydrogenase deficiency
Neu-Laxova syndrome due to 3-phosphoglycerate dehydrogenase deficiency is a rare disease catalogued by Orphanet (ORPHA:583607). It is associated with the PHGDH gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Neu-Laxova syndrome due to 3-phosphoglycerate dehydrogenase deficiency trials.
Search ClinicalTrials.gov for "Neu-Laxova syndrome due to 3-phosphoglycerate dehydrogenase deficiency" or filter by Orphanet code ORPHA:583607 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Neu-Laxova syndrome due to 3-phosphoglycerate dehydrogenase deficiency trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Neu-Laxova syndrome due to 3-phosphoglycerate dehydrogenase deficiency. Updated daily.